AIP
THRN

Ameritas Investment Partners’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Ameritas Investment Partners’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,407
Closed -$14.3K – 3136
2023
Q3 		$14.3K Buy
1,407
+888
+171% +$6.76K ﹤0.01% 2687
2023
Q2 		$2.44K Hold
519
– – ﹤0.01% 3081
2023
Q1 		$2.4K Hold
519
– – ﹤0.01% 2947
2022
Q4 		$2.12K Hold
519
– – ﹤0.01% 3007
2022
Q3 		$2K Hold
519
– – ﹤0.01% 3016
2022
Q2 		$2K Hold
519
– – ﹤0.01% 3038
2022
Q1 		$3K Hold
519
– – ﹤0.01% 3035
2021
Q4 		$3K Buy
+519
New +$4.06K ﹤0.01% 3087

Ameritas Investment Partners's THRN Position: Q4 2023 in Review

Ameritas Investment Partners sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 1,407 shares — an estimated $14.3K sold.

Ameritas Investment Partners first reported a position in THRN in Q4 2021 and held it in 8 quarters. The position peaked at $14.3K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

  • Ameritas Investment Partners reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,407 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $14.3K.
  • Ameritas Investment Partners first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Ameritas Investment Partners's Thorne Healthtech, Inc. Common Stock position peaked at $14.3K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Ameritas Investment Partners's 13F filing for Q4 2023, filed 14 Feb 2024.